Conference Call to be hosted Monday, January 26, 2026, at 10:00 AM EST TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Cerrado Gold Inc. (“Cerrado” or the “Company”) announces that it will host a management conference call on Monday, January 26th at 10:00 AM Eastern Standard Time to discuss the purported unfavourable opinion of the environmental impact assessment for the Lago Salgada Project in Portugal. Conference call details are as follows: Pre-Registration for Conference Call Participants need to preregister ...

Core Viewpoint - Cerrado Gold Inc. is facing challenges regarding the environmental impact assessment for its Lago Salgada Project in Portugal, prompting a management conference call to discuss the situation and next steps [1][2]. Company Overview - Cerrado Gold is a Toronto-based gold production, development, and exploration company, owning 100% of the Minera Don Nicolás and Las Calandrias mines in Argentina [2]. - The company holds an 80% interest in the Lagoa Salgada VMS project in Portugal and is also developing the Mont Sorcier Iron project in Canada [2][5]. Project Details - The Lagoa Salgada project is located on the Iberian Pyrite Belt and is characterized by high-grade polymetallic mineralization, including zinc, copper, lead, tin, silver, and gold [4]. - The project covers a large area of 7,209 hectares and is situated 80 km from Lisbon, benefiting from excellent infrastructure [4]. - The Mont Sorcier project aims to produce high-purity, high-grade Direct Reduced Iron, which supports the transition of steel production towards more sustainable methods [5]. Operational Strategy - In Argentina, the company is focused on optimizing operations at Minera Don Nicolás and increasing production at the Las Calandrias heap leach project [3]. - An extensive exploration campaign is underway to unlock additional resources in the Deseado Massif region [3].

Core Viewpoint - Cerrado Gold Inc. has received an unfavorable opinion from the Portuguese Environmental Agency regarding the Environmental Impact Assessment for the Lagoa Salgada Project, despite the project being deemed approved due to the expiration of the statutory deadline for a final decision [1][2][9]. Regulatory Context - Under Portuguese law, the APA was required to issue an Environmental Impact Declaration within 50 business days, which lapsed on January 22, 2026, leading to tacit approval of the EIA submitted on November 8, 2025 [2]. - The project has undergone significant improvements based on previous feedback from the APA, addressing concerns raised in May 2025 [6][10]. - The unfavorable opinion from the APA is based on potential risks to the hydrodynamic balance of aquifers, which the company argues were not previously identified and thus should not be grounds for a negative opinion [8][12]. Company Actions - The company is currently reviewing the APA's unfavorable opinion and is engaging with local authorities to seek a resolution that benefits all stakeholders [4][14]. - If constructive engagement does not yield a favorable outcome, the company plans to file a legal claim to enforce the RJAIA and confirm the project's tacit approval [5][14]. Strategic Significance - The Lagoa Salgada Project is recognized as a Project of National Interest by the Portuguese Government and aligns with the EU Critical Raw Materials Act, contributing to the secure supply of critical metals in Europe [5][15]. - The project is a high-grade polymetallic deposit containing zinc, copper, lead, tin, silver, and gold, with significant exploration potential [15][20].

Minera Don Nicolas Mine Mill at MDN Gold Equivalent Ounce ("GEO") Production of 13,806 GEO for the 4th Quarter 2025Full year production of 50,238 GEO; in line with guidance Underground Operations now delivering ore to the plant, supporting higher grade throughput and growing production 2026 Production Guidance of 50,000 to 60,000 GEO weighted to H2/26Exploration Program positioned to support resource growth at MDN with four new drill rigs now on siteDevelopment activities continue to progress at both th ...

Gold hedge completed effective January 15, 2026Company now selling 100% of production at near spot gold pricesProposed Normal Course Issuer Bid TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Cerrado Gold Inc. [TSX.V:CERT][OTCQX:CRDOF; FRA:BAI0] ("Cerrado" or the "Company") announces that it has concluded its gold hedging program that contained a ceiling of $3,250/oz on a portion of its gold sales (see news release dated May 29, 2025), delivering the final ounces required under the contract in a January 15, 2026 ...

Company Overview - Freshworks is a California-based company that develops user-friendly service software aimed at enhancing customer and employee support, utilizing a people-first approach to AI [2] - The company has a strong global presence, serving nearly 75,000 organizations, including notable brands like Bridgestone, Nucor, and S&P Global [1] Financial Performance - Freshworks reported a revenue increase of 15% year-over-year (YOY) to $215.1 million in its fiscal 2025 third-quarter earnings, surpassing analysts' expectations [7] - The company posted a GAAP loss of $0.02 per share, but on an adjusted basis, non-GAAP EPS reached $0.16, reflecting a 45% YOY increase and exceeding Wall Street's estimate by 25.5% [8] - The balance sheet remains robust, with cash, cash equivalents, and marketable securities totaling $813.2 million as of September 30, 2025 [8] Future Outlook - Management anticipates full-year revenue between $833.1 million and $836.1 million, indicating approximately 16% annual growth, with non-GAAP EPS projected between $0.62 and $0.64 [9] - Analysts expect the company's GAAP loss to narrow by nearly 88% in 2025, indicating progress towards sustained profitability [9] Market Sentiment - Freshworks stock currently has a market capitalization of about $3.3 billion and has experienced a 27% decline in 2025, leading to a valuation reset [6] - The stock trades at 16.5 times forward earnings, which is significantly lower than the sector median, placing it in bargain territory [6] - Wall Street maintains a "Moderate Buy" consensus on FRSH, with eight out of 16 analysts recommending a "Strong Buy" [10] Price Targets - The average price target for Freshworks is $18.46, suggesting a potential upside of 57%, while the highest target of $27 indicates a possible increase of 129% [11]

Core Insights - Certara, Inc. operates in the healthcare information services sector, focusing on biosimulation and regulatory expertise to enhance drug development processes [1] - The company's shares are currently priced at $8.74, reflecting an 18% decline over the past year, significantly underperforming the S&P 500 by 34.5 percentage points [2] Company Performance - Certara's stock experienced a sharp decline of approximately 23% following its latest earnings report, which was interpreted as a reset of expectations rather than a fundamental business failure [5] - The company reported a 10% year-over-year revenue growth in the third quarter, with software revenue increasing by 22%, and it returned to positive net income while raising its full-year profitability outlook [5] Investment Activity - Kopion Asset Management acquired an additional 327,064 shares of Certara, valued at approximately $3.37 million, during the quarter ending December 31, indicating confidence in the company's long-term prospects [3][4] - The value of Kopion's position in Certara increased by $645,681 over the quarter, reflecting both new purchases and positive price movement [4] Market Position - Certara's biosimulation software and regulatory services are integral to drug development workflows, characterized by high switching costs and persistent demand, even in tighter budget environments [6] - The company operates in a defensible niche within the pharmaceutical R&D technology market, which may provide resilience against market fluctuations [6]

Core Insights - Certara, Inc. has appointed Jon Resnick as the new CEO effective January 1, 2026, succeeding William Feehery, who will transition to an advisory role [1][3] - The company reaffirms its financial outlook for the full year 2025 as previously disclosed [4] Leadership Transition - Jon Resnick brings over 20 years of experience from IQVIA, where he held various leadership roles, including President of the U.S. and Canada regional business [2][3] - William Feehery has been credited with guiding Certara through its successful IPO and reinforcing its position as a global leader in biosimulation [4] Company Strategy and Vision - Resnick expressed enthusiasm about leading Certara, emphasizing the company's unique position in drug discovery and development through AI, data, and simulation technologies [3] - The company serves over 2,400 clients, including biopharmaceutical companies and regulatory agencies across 70 countries, highlighting its extensive market reach [5]

Core Viewpoint - Certara, Inc. (CERT) is positioned as a strong investment opportunity due to a significant revision in earnings estimates, indicating a positive earnings outlook and potential for continued stock price growth [1][2]. Earnings Estimate Revisions - The trend in earnings estimate revisions reflects growing analyst optimism about Certara's earnings prospects, which is expected to influence its stock price positively [2]. - For the current quarter, Certara is projected to earn $0.12 per share, a decrease of 20.0% from the previous year, but the Zacks Consensus Estimate has increased by 7.69% over the last 30 days due to two upward revisions [6]. - For the full year, the earnings estimate is $0.46 per share, representing a year-over-year increase of 2.2%, with three estimates moving up and pushing the consensus estimate 10.9% higher [7][8]. Zacks Rank and Performance - Certara has achieved a Zacks Rank 2 (Buy), indicating favorable estimate revisions that suggest strong potential for outperformance compared to the S&P 500 [9]. - Historically, Zacks 1 (Strong Buy) and 2 (Buy) stocks have significantly outperformed the S&P 500, with Zacks 1 stocks averaging a +25% annual return since 2008 [3][9]. Recent Stock Performance - Certara shares have increased by 6.3% over the past four weeks, reflecting investor confidence in the company's earnings growth prospects [10].

Core Viewpoint - Certara, Inc. (CERT) shows potential for significant upside, with a mean price target of $13.21 indicating a 43.3% increase from the current price of $9.22 [1] Price Targets and Analyst Estimates - The mean estimate consists of 12 short-term price targets with a standard deviation of $2.59, indicating variability among analysts; the lowest estimate is $9.00 (2.4% decline), while the highest is $16.00 (73.5% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about Certara's earnings prospects, as indicated by a positive trend in earnings estimate revisions; three estimates have increased over the last 30 days, leading to a 10.9% rise in the Zacks Consensus Estimate [11][12] - Certara holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] Caution on Price Targets - While price targets are often sought after by investors, they can mislead; empirical research shows that they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]